IZBA
Live / Registered — Registered (as of 21 Feb 2023)
What this means for you
Registered since 21 Feb 2023. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 21 Feb 2029: the §71 affidavit of use).
Record
- Serial number
- 79350102
- Registration number
- 6982662
- Mark type
- Word mark
- Filed
- 12 Aug 2022
- Published for opposition
- 06 Dec 2022
- Registered
- 21 Feb 2023
- Next maintenance filing
- §71 affidavit of use, due by 21 Feb 2029 (grace period to 21 Aug 2029)
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Ophthalmic preparations
Owner
- Novartis AG, CH
- Novartis AG, CH
- Novartis AG, CH
Prosecution history
- 09 May 2023 — NOTIFICATION PROCESSED BY IB
- 06 Apr 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 06 Apr 2023 — FINAL DISPOSITION PROCESSED
- 23 Mar 2023 — GRANT OF PROTECTION CREATED, TO BE SENT TO IB
- 21 Feb 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Feb 2023 — REGISTERED-PRINCIPAL REGISTER
- 27 Dec 2022 — INTERNATIONAL REGISTRATION RENEWED
- 20 Dec 2022 — NOTIFICATION PROCESSED BY IB
- 06 Dec 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Dec 2022 — PUBLISHED FOR OPPOSITION
- 23 Nov 2022 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 23 Nov 2022 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 16 Nov 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 31 Oct 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 Oct 2022 — ASSIGNED TO EXAMINER